Gastroenterology
Volume 132, Issue 5 , Pages 2022-2044 , May 2007

AGA Institute Technical Review on Acute Pancreatitis

  • Chris E. Forsmark

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida
    • Corresponding Author InformationAddress requests for reprints to: Chair, Clinical Practice and Economics Committee, AGA Institute National Office, c/o Membership Department, 4930 Del Ray Avenue, Bethesda, Maryland 20814. Fax: (301) 654-5920.
    • ,
  • John Baillie

      Affiliations

    • Gastroenterology Section, Wake Forest University School of Medicine, Winston-Salem, North Carolina

References 

  1. Lowenfels AB, Sullivan T, Fiorianti J, Maisonneuve P. The epidemiology and impact of pancreatic diseases in the United States. Curr Gastroenterol Rep. 2005;7:90–95
  2. Corfield AP, Cooper MJ, Williamson RC. Acute pancreatitis; a lethal disease of increasing incidence. Gut. 1985;26:724–729
  3. Wilson C, Imire CW, Carter DC. Fatal acute pancreatitis. Gut. 1988;29:782–788
  4. Lankisch PG, Schirren CA, Kunze E. Undetected fatal acute pancreatitis: why is the disease so frequently overlooked?. Am J Gastroenterol. 1991;86:322–326
  5. Kemppainen EA, Hedstrom JI, Puolakkainen PA, Sainio VS, Haapiainen RK, Perhoniemi V, et al. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med. 1997;337:1394–1395
  6. Gumaste VV, Roditis N, Mehta D, Dave PB. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis. Am J Gastroenterol. 1993;88:2051–2055
  7. Treacy J, Williams A, Bais R, Willson K, Worthley C, Reece J, et al. Evaluation of amylase and lipase in the diagnosis of acute pancreatitis. ANZ J Surg. 2001;71:577–582
  8. Gwozdz GP, Steinberg WM, Werner M, Henry JP, Pauley C. Comparative evaluation of the diagnosis of acute pancreatitis based on serum and urine enzyme assays. Clin Chim Acta. 1990;187:243–254
  9. Kylanpaa-Back ML, Kemppainen E, Puolakkaninen P, Hedstrom J, Haapiainen R, Korvuo A, et al. Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis. Hepatogastroenterology. 2002;49:1130–1134
  10. Steinberg WM, Goldstein SS, Davis ND, Shamma’a J, Anderson K. Diagnostic assays in acute pancreatitis (A study of sensitivity and specificity). Ann Intern Med. 1985;102:576–580
  11. Sternby B, O’Brien JF, Zinsmeister AR, DiMagno EP. What is the best biochemical test to diagnose acute pancreatitis? (A prospective clinical study). Mayo Clin Proc. 1996;71:1138–1144
  12. Seno T, Harada H, Ochi K, Tanaka J, Matsumoto S, Choudhury R, et al. Serum levels of six pancreatic enzymes as related to the degree of renal dysfunction. Am J Gastroenterol. 1995;90:2002–2005
  13. Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol. 2002;97:1309–1318
  14. Wang SS, Lin XZ, Tsai YT, Lee SD, Pan HB, Chou YH, et al Clinical significance of ultrasonography, computed tomography, and biochemical tests in the rapid diagnosis of gallstone-related pancreatitis: a prospective study. Pancreas. 1988;3:153–158
  15. Neoptolemos JP, Hall AW, Finlay DF, Berry JM, Carr-Locke DL, Fossard DP. The urgent diagnosis of gallstones in acute pancreatitis: a prospective study of three methods. Br J Surg. 1984;71:230–233
  16. Balthazar EJ. CT diagnosis and staging of acute pancreatitis. Radiol Clin North Am. 1989;27:19–37
  17. Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology. 2002;223:603–613
  18. Kalra MK, Maher MM, Sahani DV, Digmurthy S, Saini S. Current status of imaging in pancreatic diseases. Comput Assist Tomogr. 2002;26:661–675
  19. Foitzik T, Bassi DG, Schmidt J, Lewandrowski KB, Fernandez-del Castillo C, Rattner DW, et al. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat. Gastroenterology. 1994;106:207–214
  20. Balthazar EJ, Freeny PC. Contrast-enhanced computed tomography in acute pancreatitis: is it beneficial or harmful?. Gastroenterology. 1994;106:259–262
  21. Hwang TL, Chang KY, Ho YP. Contrast-enhanced dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis: reevaluation of the effect of intravenous contrast medium on the severity of acute pancreatitis. Arch Surg. 2000;135:287–290
  22. Plock JA, Schmidt J, Anderson SE, Sarr MG, Roggo A. Contrast-enhanced computed tomography in acute pancreatitis: does contrast medium worsen its course due to impaired microcirculation?. Langenbecks Arch Surg. 2005;390:156–163
  23. Pamuklar E, Semelka RC. MR imaging of the pancreas. Magn Reson Imaging Clin North Am. 2005;13:313–330
  24. Matos C, Bali MA, Delhaye M, Deviere J. Magnetic resonance imaging in the detection of pancreatitis and pancreatic neoplasms. Best Pract Res Clin Gastroenterol. 2006;20:157–178
  25. Arvanitakis M, Delhaye M, De Maertelaere V, Bali M, Winant C, Coppens E, et al. Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology. 2004;126:715–723
  26. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, et al. Digestive and liver diseases statistics, 2004. Gastroenterology. 2004;126:1448–1453
  27. Talamini G, Bassi C, Falconi M, Sartori N, Frulloni L, Di Francesco V, et al. Risk of death from acute pancreatitis (Role of early, simple “routine” data). Int J Pancreatol. 1996;19:15–24
  28. Mann DV, Hershman MJ, Hittinger R, Glazer G. Multicentre audit of death from acute pancreatitis. Br J Surg. 1994;81:890–893
  29. Carnovale A, Rabitti PG, Manes G, Esposito P, Pacelli L, Uomo G. Mortality in acute pancreatitis: is it an early or late event?. JOP. 2005;6:438–444
  30. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg. 1999;86:1302–1305
  31. Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler MW. Late mortality in patients with severe acute pancreatitis. Br J Surg. 2001;88:975–979
  32. Bradley EL. A clinically based classification system for acute pancreatitis (Summary of the International Symposium on Acute Pancreatitis, Atlanta GA, September 11, through 13, 1992). Arch Surg. 1993;128:586–590
  33. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139:69–81
  34. Ranson JH. The timing of biliary surgery in acute pancreatitis. Ann Surg. 1979;189:654–663
  35. Larvin M. Assessment of clinical severity and prognosis. In:  Beger HG,  Warshaw AL,  Buchler MW,  Carr-Locke D,  Neoptolemos JP,  Russell C,  Sarr MG editor. The pancreas. Oxford: Blackwell Science; 1998;p. 489–502
  36. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O’Neill J, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65:337–341
  37. Osborne DH, Imrie CW, Carter DC. Biliary surgery in the same admission for gallstone-associated acute pancreatitis. Br J Surg. 1981;68:758–761
  38. Blamey SL, Imrie CW, O’Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984;25:1340–1346
  39. Agarwal N, Pitchumoni CS. Simplified prognostic criteria in acute pancreatitis. Pancreas. 1986;1:69–73
  40. Rabeneck L, Feinstein AR, Horwitz RI, Wells CK. A new clinical prognostic staging system for acute pancreatitis. Am J Med. 1993;95:61–70
  41. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet. 1989;2:201–205
  42. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring system. Br J Surg. 1990;77:1260–1264
  43. Dominguez-Munoz JE, Carballo F, Garcia MJ, de Diego JM, Campos R, Yanguela J, et al. Evaluation of the clinical usefulness of APACHE II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study. Pancreas. 1993;8:682–686
  44. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963
  45. Chatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. J Clin Gastroenterol. 2003;36:253–260
  46. Spitzer AL, Barcia AM, Schell MT, Barber A, Norman J, Grendell J, et al. Applying Ockham’s razor to pancreatitis prognostication: a four-variable predictive model. Ann Surg. 2006;243:380–388
  47. Pearce DB, Gunn SR, Ahmed A, Johnson CD. Machine learning can improve prediction of severity in acute pancreatitis using admission values of APACHE II score and C-reactive protein. Pancreatology. 2006;6:123–131
  48. Werner J, Feuerbach S, Uhl W, Buchler MW. Management of acute pancreatitis: from surgery to interventional intensive care. Gut. 2005;54:426–436
  49. Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg. 2006;93:738–744
  50. Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Diaz G, Perez-Mateo M. Obesity is a definitive risk factor of severity and morality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6:206–209
  51. Johnson DC, Toh SK, Campbell MJ. Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Pancreatology. 2004;4:1–6
  52. Papachristou GI, Papachristou DJ, Avula H, Slivka A, Whitcomb DC. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology. 2006;6:279–285
  53. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174:331–336
  54. London NJ, Leese T, Lavelle JM, Miles K, West KP, Watkin DF, et al. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study. Br J Surg. 1991;78:1452–1456
  55. Simchuk EJ, Traverso LW, Nukui YM, Kozarek RA. Computed tomography severity index is a predictor of outcomes for severe pancreatitis. Am J Surg. 2000;179:352–355
  56. Perez A, Whang EE, Brooks DC, Moore FD, Hughes MD, Sica GT, et al. Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis?. Pancreas. 2002;25:229–233
  57. Garg PK, Madan K, Pande GK, Khanna S, Sathyanarayan G, Bohidar NP, et al. Association of extent and infection of pancreatic necrosis with organ failure and death in acute necrotizing pancreatitis. Clin Gastroenterol Hepatol. 2005;3:159–166
  58. Karimgani I, Porter KA, Langevin RE, Banks PA. Prognostic factors in sterile pancreatic necrosis. Gastroenterology. 1992;103:1636–1640
  59. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology. 1997;113:899–903
  60. Hirota M, Kimura Y, Ishiko T, Beppu T, Yamashita Y, Ogawa M. Visualization of the heterogeneous internal structure of so-called “pancreatic necrosis” by magnetic resonance imaging in acute necrotizing pancreatitis. Pancreas. 2002;25:63–67
  61. Matos C, Bali MA, Delhaye M, Deviere J. Magnetic resonance imaging in the detection of pancreatitis and pancreatic neoplasms. Best Pract Clin Gastroenterol. 2006;20:157–178
  62. Robert JH, Frossard JL, Mermillod B, Soravia C, Mensi N, Roth M, et al. Early prediction of acute pancreatitis: prospective study comparing computed tomography scans, Ranson, Glasgow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers. World J Surg. 2002;26:612–619
  63. Gurleyik G, Emir S, Kilicoglu G, Arman A, Saglam A. Computed tomography severity index, APACHE II score, and serum CRP concentration for predicting the severity of acute pancreatitis. JOP. 2005;6:562–567
  64. De Sanctis JT, Lee MJ, Gazelle GS, Boland GW, Halpern EF, Saini S, et al. Prognostic indicators in acute pancreatitis: CT vs. APACHE II. Clin Radiol. 1997;52:842–848
  65. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas. 2001;22:274–278
  66. Buter A, Imrie CW, Carter CR, Evans S, McKay CJ. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg. 2002;89:298–302
  67. Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut. 2004;53:1340–1344
  68. Poves Prim I, Fabregat Pous J, Garcia Borobia FJ, Jorba Marti R, Figueras Felip J, Jaurrieta Mas E. Early onset of organ failure is the best predictor of morality in acute pancreatitis. Rev Esp Enferm Dig. 2004;96:705–713
  69. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638–1652
  70. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure (On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine). Intensive Care Med. 1996;22:707–710
  71. Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas. 2000;20:367–372
  72. Lankisch PG, Mahlke R, Blum T, Bruns A, Bruns D, Maisonneuve P, et al. Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? (A critical appraisal). Am J Gastroenterol. 2001;96:2081–2085
  73. Baillargeon JD, Orav J, Ramagopal V, Tenner SM, Banks PA. Hemoconcentration as an early risk factor for necrotizing pancreatitis. Am J Gastroenterol. 1998;93:2130–2134
  74. Remes-Troche JM, Duarte-Rojo A, Morales G, Robles-Diaz G. Hemoconcentration is a poor predictor of severity in acute pancreatitis. World J Gastroenterol. 2005;11:7018–7023
  75. Blum T, Maisonneuve P, Lowenfels AB, Lankisch PG. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology. 2001;1:273–241
  76. Rettally C, Skarda S, Garza MA, Schenker S. The usefulness of laboratory tests in the early assessment of severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2003;40:117–149
  77. Kingsnorth A, O’Reilly D. Acute pancreatitis. BMJ. 2006;332:1072–1076
  78. Whitcomb DC. Clinical practice (Acute pancreatitis). N Engl J Med. 2006;354:2142–2150
  79. Chak A, Hawes RH, Cooper GS, Hoffman B, Catalano MF, Wong RC, et al. Prospective assessment of the utility of EUS in the evaluation of gallstone pancreatitis. Gastrointest Endosc. 1999;49:599–604
  80. Liu CL, Lo CM, Chan JK, Poon RT, Lam CM, Fan ST, et al. Detection of choledocholithiasis by EUS in acute pancreatitis: a prospective evaluation in 100 consecutive patients. Gastrointest Endosc. 2001;54:325–330
  81. Ammori BJ, Boreham B, Lewis P, Roberts SA. The biochemical detection of biliary etiology of acute pancreatitis on admission: a revisit in the modern era of biliary imaging. Pancreas. 2003;26:e32–e35
  82. Levy P, Boruchowicz A, Hastier P, Pariente A, Thevenot T, Frossard JL, et al. Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients. Pancreatology. 2005;5:450–456
  83. Liu CL, Fan ST, Lo CM, Tso WK, Wong Y, Poon RT, et al. Clinico-biochemical prediction of biliary cause of acute pancreatitis in the era of endoscopic ultrasonography. Aliment Pharmacol Ther. 2005;22:423–431
  84. Steinberg WM, Chari ST, Forsmark CE, Sherman S, Reber HA, Bradley EL, et al. Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis. Pancreas. 2003;27:103–117
  85. Steinberg WM. Controversies in clinical pancreatology: should the sphincter of Oddi be measured in patients with idiopathic recurrent acute pancreatitis, and should sphincterotomy be performed if the pressure is high?. Pancreas. 2003;27:118–121
  86. Petersen BT. Sphincter of Oddi dysfunction, part 2: evidence-based review of the presentations, with “objective” pancreatic findings (types I and II) and of presumptive type III. Gastrointest Endosc. 2004;59:670–687
  87. Runzi M, Layer P. Drug-associated pancreatitis: facts and fiction. Pancreas. 1996;13:100–109
  88. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003;17:887–893
  89. Lara LP, Chari ST. Autoimmune pancreatitis. Curr Gastroenterol Rep. 2005;7:101–106
  90. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010–1016
  91. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14:141–145
  92. Vitone LJ, Greenhalf W, Howes NR, Raraty MG, Neoptolemos JP. Trypsinogen mutations in pancreatic disorders. Endocrinol Metab Clin North Am. 2006;35:271–287
  93. Cohn JA, Noone PG, Jowell PS. Idiopathic pancreatitis related to CFTR: complex inheritance and identification of a modifier gene. J Invest Med. 2002;50:247S–255S
  94. Cohn JA, Bornstein JD, Jowell PS. Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis. Med Clin North Am. 2000;84:621–631
  95. Gelrud A, Sheth S, Banerjee S, Weed D, Shea J, Chuttani R, et al. Analysis of cystic fibrosis gene product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol. 2004;99:1557–1562
  96. Schneider A. Serine protease inhibitor kazal type 1 mutations and pancreatitis. Clin Lab Med. 2005;25:61–78
  97. Tukiainen E, Kylanpaa ML, Kemppainen E, Nevanlinna H, Paju A, Repo H, et al. Pancreatic secretory trypsin inhibitor (SPINK1) gene mutations in patients with acute pancreatitis. Pancreas. 2005;30:239–242
  98. Evans WB, Draganov P. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statements. 2002;19:1–26
  99. Evans WB, Draganov P. Is empiric cholecystectomy a reasonable treatment option for idiopathic pancreatitis?. Nat Clin Pract Gastroenterol Hepatol. 2006;3:356–357
  100. Draganov P, Forsmark CE. “Idiopathic” pancreatitis. Gastroenterology. 2005;128:756–763
  101. Wilcox MC, Varadarajulu S, Eloubeidi M. Role of endoscopic evaluation in idiopathic pancreatitis: a systematic review. Gastrointest Endosc. 2006;63:1037–1045
  102. Ballinger AB, Barnes E, Alstead EM, Fairclough PD. Is intervention necessary after a first episode of acute pancreatitis?. Gut. 1996;38:293–295
  103. Lankisch PG, Breuer N, Bruns A, Weber-Dany B, Maisonneuve P, Lowefels P. The natural course of acute idiopathic pancreatitis (abstr). Pancreas. 2006;33:476
  104. Knol JA, Inman MG, Strodel WE, Eckhauser FE. Pancreatic response to crystalloid resuscitation in experimental pancreatitis. J Surg Res. 1987;43:387–392
  105. Niederau C, Crass RA, Silver G, Ferrell LD, Grendell JH. Therapeutic regimens in acute experimental hemorrhagic pancreatitis (Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor). Gastroenterology. 1988;95:1648–1657
  106. Brown A, Baillargeon JD, Hughes MD, Banks PA. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis?. Pancreatology. 2002;2:104–107
  107. Beger HG, Bittner R, Buchler M, Hess W, Schmitz JE. Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology. 1986;90:74–79
  108. Forsmark CE, Grendell JH. Complications of pancreatitis. In:  Sleisenger MH,  Fordtran JS,  Cello JP,  Grendell JH editor. Seminars in gastrointestinal disease: diagnosis and treatment of acute and chronic pancreatitis. Philadelphia, PA: Saunders; 1991;p. 165–176
  109. Turina M, Fry DE, Polk HC. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33:1624–1633
  110. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36:54–62
  111. Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001;96:1266–1272
  112. Kaushik N, Pietraszewski M, Holst JJ, O’Keefe SJ. Enteral feeding without pancreatic stimulation. Pancreas. 2005;31:353–359
  113. Vu MK, van der Veek PP, Frolich M, Souverijn JH, Biemond I, Lamers CB, et al. Does jejunal feeding activate exocrine pancreatic secretion?. Eur J Clin Invest. 1999;29:1053–1059
  114. Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ. 2004;328:1407
  115. O’Keefe SJ, Lee RB, Anderson FP, Gennings C, Abou-Assi S, Clore J, et al. Physiological effects of enteral and parenteral feeding on pancreaticobillary secretion in humans. Am J Physiol Gastrointest Liver Physiol. 2003;284:G27–G36
  116. O’Keefe SJ, Lee RM, Li J, Stevens S, Abou-Assi S, Zhou W. Trypsin secretion and turnover in patients with acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2005;289:G181–G187
  117. Eatock FC, Chong P, Menezes N, Murray L, McKay CJ, Carter CR, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol. 2005;100:432–439
  118. Kumar A, Singh N, Prakash S, Saraya A, Joshi YK. Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes. J Clin Gastroenterol. 2006;40:431–434
  119. Eckerwall GE, Axelsson JB, Andersson RG. Early nasogastric feeding in predicted severe acute pancreatitis: a clinical, randomized study. Ann Surg. 2006;244:959–967
  120. Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, et al. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther. 1998;12:237–245
  121. Uhl W, Buchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut. 1999;45:97–104
  122. Messori A, Rampazzo R, Scroccaro G, Olivato R, Bassi C, Falconi M, et al. Effectiveness of gabexate mesilate in acute pancreatitis (A metaanalysis). Dig Dis Sci. 1995;40:734–738
  123. Larvin M. A double-blind randomized multi-centre trial of lexipafant in acute pancreatitis (abstr). Pancreas. 2001;23:448
  124. Forsmark CE. The clinical problem of biliary acute necrotizing pancreatitis: epidemiology, pathophysiology, and diagnosis of biliary necrotizing pancreatitis. J Gastrointest Surg. 2001;5:235–239
  125. Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet. 1988;2:979–983
  126. Fan ST, Lai EC, Mok FP, Lo CM, Zheng SS, Wong J. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med. 1993;328:228–232
  127. Folsch UR, Nitsche R, Ludtke R, Hilgers RA, Creutzfeldt W. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis (The German Study Group on Acute Biliary Pancreatitis). N Engl J Med. 1997;336:237–242
  128. Oria A, Cimmino D, Ocampo C, Silva W, Kohan G, Zandalazini H, et al. Early endoscopic intervention versus early conservative management in patients with acute gallstone pancreatitis and biliopancreatic obstruction (A randomized clinical trial). Ann Surg. 2007;245:10–17
  129. Sharma VK, Howden CW. Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis. Am J Gastroenterol. 1999;94:3211–3214
  130. Heinrich S, Schafer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006;243:154–168
  131. Aybu K, Imada R, Slavin J. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis. Cochrane Database Syst Rev. 2004;CD003630
  132. Davidson BR, Neoptolemos JP, Carr-Locke DL. Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery. Gut. 1988;29:114–120
  133. Shemesh E, Czerniak A, Schneabaum S, Nass S. Early endoscopic sphincterotomy in the management of acute gallstone pancreatitis in elderly patients. J Am Geriatr Soc. 1990;38:893–896
  134. Hill J, Martin DF, Tweedle DE. Risks of leaving the gallbladder in situ after endoscopic sphincterotomy for bile duct stones. Br J Surg. 1991;78:554–557
  135. Siegel JH, Veerappan A, Cohen SA, Kasmin FE. Endoscopic sphincterotomy for biliary pancreatitis: an alternative to cholecystectomy in high-risk patients. Gastrointest Endosc. 1994;40:573–575
  136. Wellbourn CR, Beckly DE, Eyre-Brook IA. Endoscopic sphincterotomy without cholecystectomy for gall stone pancreatitis. Gut. 1995;37:119–120
  137. Uomo G, Manes G, Laccetti M, Cavallera A, Rabitti PG. Endoscopic sphincterotomy and recurrence of acute pancreatitis in gallstone patients considered unfit for surgery. Pancreas. 1997;14:28–31
  138. Gislason H, Vetrhus M, Horn A, Hoem D, Sondenaa K, Soreide O, et al. Endoscopic sphincterotomy in acute gallstone pancreatitis: a prospective study of the late outcome. Eur J Surg. 2001;167:204–208
  139. Kaw M, Al-Antably Y, Kaw P. Management of gallstone pancreatitis: cholecystectomy or ERCP and endoscopic sphincterotomy. Gastrointest Endosc. 2002;56:61–65
  140. Erickson RA, Carlson B. The role of endoscopic retrograde cholangiopancreatography in patients with laparoscopic cholecystectomies. Gastroenterology. 1995;109:252–263
  141. Chang L, Lo S, Stabile BE, Lewis RJ, Toosie K, de Virgilio C. Preoperative versus postoperative endoscopic retrograde cholangiopancreatography in mild to moderate gallstone pancreatitis: a prospective randomized trial. Ann Surg. 2000;231:82–87
  142. Urbach DR, Khajanchee YS, Jobe BA, Standage BA, Hansen PD, Swanstrom LL. Cost-effective management of common bile duct stones: a decision analysis of the use of endoscopic retrograde cholangiopancreatography (ERCP) intraoperative cholangiography, and laparoscopic bile duct exploration. Surg Endosc. 2001;15:4–13
  143. Liu CL, Fan ST, Lo CM, Tso WK, Wong Y, Poon RT, et al. Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol. 2005;3:1238–1244
  144. Pederzoli P, Bassi C, Vesentini S, Campbedelli A. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176:480–483
  145. Luiten EJ, Hop WC, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57–65
  146. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L, Valtonen V, et al. Early antibiotic treatment in acute necrotizing pancreatitis. Lancet. 1995;346:663–667
  147. Delcenserie R, Yzet T, Ducrois JP. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas. 1996;13:198–201
  148. Schwarz M, Isenmann R, Meyer H, Berger HG. Antibiotic use in necrotizing pancreatitis (Results of a controlled study). Dtsch Med Wochenschr. 1997;122:356–361
  149. Nordback I, Sand J, Saaristo R, Paajanen J. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis—a single-center randomized study. J Gastrointest Surg. 2001;5:113–118discussion 118–120
  150. Isenmann R, Runzi M, Kron M, Kahl S, Kraus D, Jung N, et al. German Antibiotics in Severe Acute Pancreatitis Study Group (Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial). Gastroenterology. 2004;126:997–1004
  151. Dellinger RP, Tellado JM, Soto NE, Ashley SW, Barie PS, Dugernier T, Imrie CW, Johnson CD, Knaebel HP, Laterre PF, Maravi-Poma E, Kissler JJO, Sanchez-Garcia M, Utzolino S. Early antibiotic treatment for severe acute necrotizing pancreatitis: Randomized, double-blind, placebo-controlled study. Ann Surg (in press).
  152. Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2003;CD002941
  153. Moyshenyat I, Mandell E, Tenner S. Antibiotic prophylaxis of pancreatic infection in patients with necrotizing pancreatitis: rationale, evidence, and recommendations. Curr Gastroentrol Rep. 2006;8:121–126
  154. Besselink MGH, de Vries AC, van de Kraats CIB, Buskens E, Van Erpecum KJ, Gooszen HG. Antibiotic prophylaxis in necrotizing pancreatitis: relationship of methodological quality of randomized trials to outcome (abstr). Pancreas. 2006;33:446
  155. Working Party of the British Society of GastroenterologyAssociation of Surgeons of Great Britain and IrelandPancreatic Society of Great Britain and IrelandAssociation of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut. 2005;54(Suppl 3):iii1–iii9
  156. Bassi C, Falconi M, Talamini G, Uomo G, Papaccio G, Dervenis C, et al. Controlled clinical trial of perfloxacin versus imipenem in severe acute pancreatitis. Gastroenterology. 1998;115:1513–1517
  157. Gerzof SG, Banks PA, Robbins AH, Johnson WC, Spechler SJ, Wetzner SM, et al. Early diagnosis of pancreatic infection by computed tomography-guided aspiration. Gastroenterology. 1987;93:1315–1320
  158. Banks PA, Gerzof SG, Langevin RE, Silverman SG, Sica GT, Hughes MD. CT-guided aspiration of suspected pancreatic infection: bacteriology and clinical outcome. Int J Pancreatol. 1995;18:265–270
  159. Rau B, Pralle U, Mayer JM, Berger HG. Role of ultrasonographically guided fine-needle aspiration cytology in the diagnosis of infected pancreatic necrosis. Br J Surg. 1998;85:179–184
  160. Connor S, Ghaneh P, Raraty M, Sutton R, Rosso E, Garvey CJ, et al. Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg. 2003;20:270–277
  161. Parekh D. Laparoscopic-assisted pancreatic necrosectomy: a new surgical option for treatment of severe necrotizing pancreatitis. Arch Surg. 2006;141:895–902discussion 902–903
  162. Chang YC, Tsai HM, Lin XZ, Chang CH, Chuang JP. No debridement is necessary for symptomatic or infected acute necrotizing pancreatitis: delayed, min-retroperitoneal drainage for acute necrotizing pancreatitis without debridement and irrigation. Dig Dis Sci. 2006;51:1388–1395
  163. Freeny PC, Hauptmann E, Althaus SJ, Traverso LW, Sinanan M. Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results. AJR Am J Roentgenol. 1998;170:969–975
  164. Szentkereszty Z, Kerekes L, Hallay J, Czako D, Sapy Y. CT-guided percutaneous peripancreatic drainage: a possible therapy in acute necrotizing pancreatitis. Hepatogastroenterology. 2002;49:1696–1698
  165. Endilcher E, Volk M, Feruerbach S, Scholmerich J, Schaffler A, Messmann H. Long-term follow-up of patients with necrotizing pancreatitis treated by percutaneous necrosectomy. Hepatogastroenterology. 2003;50:2225–2228
  166. Echenique AM, Sleeman D, Yrizarry J, Scagnelli T, Guerra JJ, Casillas VJ, et al. Percutaneous catheter-directed debridement of infected pancreatic necrosis: results in 20 patients. J Vasc Interv Radiol. 1998;9:565–571
  167. Baron TH, Thaggard WG, Morgan DE, Stanley RJ. Endoscopic therapy for organized pancreatic necrosis. Gastroenterology. 1996;111:755–764
  168. Baron TH, Harewood GC, Morgan DE, Yates MR. Outcome differences after endoscopic drainage of pancreatic necrosis acute pancreatic pseudocysts, and chronic pancreatic pseudocysts. Gastrointest Endosc. 2002;56:7–17
  169. Baron TH. Endoscopic drainage of pancreatic fluid collections and pancreatic necrosis. Gastrointest Endosc Clin North Am. 2003;13:743–764
  170. Seewald S, Groth S, Omar S, Imazu H, Seitz U, de Weerth A, et al. Aggressive endoscopic therapy for pancreatic necrosis and pancreatic abscess: a new safe and effective treatment algorithm (videos). Gastrointest Endosc. 2005;62:92–100
  171. Vege SS, Baron TH. Management of pancreatic necrosis in severe acute pancreatitis. Clin Gastroenterol Hepatol. 2005;3:192–196
  172. Dubner H, Steinberg W, Hill M, Bassi C, Chardavoyne R, Bank S. Infected pancreatic necrosis and peripancreatic fluid collections: serendipitous response to antibiotics and medical therapy in three patients. Pancreas. 1996;12:298–302
  173. Ramesh H, Prakash K, Lekha V, Jacob G, Venugopal A. Are some cases of infected pancreatic necrosis treatable without intervention?. Dig Surg. 2003;20:296–299
  174. Baillie J. Pancreatic pseudocysts (part I). Gastrointest Endosc. 2004;59:873–879
  175. Baillie J. Pancreatic pseudocysts (part II). Gastrointest Endosc. 2004;60:105–113
  176. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425–434
  177. Cheng C-L, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139–147
  178. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–918
  179. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56:652–656
  180. Friedland S, Soetikno RM, Vandervoort J, Montes H, Tham T, Carr-Locke DL. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy. 2002;34:483–438
  181. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: A prospective multicenter study. Am J Gastroenterol. 2001;96:417–423
  182. Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta analysis. Endoscopy. 2003;35:830–834
  183. Cotton PB. ERCP is not dangerous for people who need it least. Gastrointest Endosc. 2001;54:535–536
  184. ERCP core curriculum. Gastrointest Endosc. 2006;63:361–376
  185. Pande H, Thuluvath P. Pharmacologic prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Drugs. 2003;63:1799–1812
  186. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59:845–864
  187. Andruilli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc. 2000;51:1–7
  188. Andriulli A, Caruso N, Quitadamo M, Forlano R, Leandro G, Spirito F, et al. Antisecretory vs. antiproteases drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP. 2003;4:41–48
  189. Murray B, Carter R, Imrie C, Evans S, O’Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiography. Gastroenterology. 2003;124:1786–1791
  190. Singh P, Das A, Isenberg G, Wong RC, Sivak MV, Agrawal D, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? (A meta-analysis of controlled trials). Gastrointest Endosc. 2004;60:544–550
  191. Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc. 2004;59:8–14

 This literature review and the recommendations therein were prepared for the AGA Institute Clinical Practice and Economics Committee. The paper was approved by the Committee on February 14, 2007, and by the AGA Institute Governing Board on March 15, 2007.

PII: S0016-5085(07)00591-4

doi: 10.1053/j.gastro.2007.03.065

Gastroenterology
Volume 132, Issue 5 , Pages 2022-2044 , May 2007

Article Tools